The aim of Biotechnological, Biocomputational, Pharmaceutical and Pharmacological Science (B2F2) program is to train talented and motivated young researchers to become experts in the biotechnology, bioinformatics, pharmaceutical and pharmacological fields and to favor their enrollment in pharmaceutical and biotech companies, or in the related health care sector and research institutions. The B2F2 PhD program offers top-level research and training on complementary skills in a truly multidisciplinary research environment.
Our three-year program provides outstanding students with excellent interdisciplinary, research-oriented studies in biotechnological, biocomputational, pharmaceutical and pharmacological sciences. We train full-time students to acquire and utilize the skills necessary for their research projects focused on the discovery of new therapeutic targets, as well as new drugs and their formulation, and to study their profile of efficacy and safety. The discovery of novel drug targets, in fact, is followed by the design, synthesis and analysis of new drugs, and the investigation of how they perturb receptors, enzymes or intracellular signaling pathways contributing to a specific disease onset and progression. It is proposed to PhD students an integrated cross training, useful for their future employment access in pharmaceutical and biotechnology companies.
The aim is to create multi-disciplinary projects involving different research teams of the University of Bologna, the majority at the Department of Pharmacy and Biotechnology. PhD students are expected to benefit from the informal network with foreign partner organizations. The majority of their training period will be spent at the University of Bologna. Mobility of enrolled students towards foreign organizations for six months is mandatory. This exchange gives students the chance to experience working in a different country and to promote international collaboration and mobility.